Weld Capital Management’s Gilead Sciences GILD Stock Holding History

Weld Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,050	Closed	-$417K	–	78
2021 Q2	$417K	Buy	+6,050	New	+$404K	0.42%	91
2020 Q3	–	Sell	-5,351	Closed	-$412K	–	551
2020 Q2	$412K	Sell	5,351 -4,763	-47%	-$365K	0.16%	214
2020 Q1	$756K	Sell	10,114 -2,793	-22%	-$193K	0.39%	79
2019 Q4	$839K	Buy	12,907 +1,020	+9%	+$66.4K	0.16%	221
2019 Q3	$753K	Buy	+11,887	New	+$777K	0.14%	248
2019 Q2	–	Sell	-23,756	Closed	-$1.54M	–	822
2019 Q1	$1.54M	Buy	23,756 +16,028	+207%	+$1.07M	0.28%	90
2018 Q4	$483K	Buy	+7,728	New	+$540K	0.11%	358

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Weld Capital Management's GILD Position: Q3 2021 in Review

Weld Capital Management sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 6,050 shares — an estimated $417K sold.

Weld Capital Management first reported a position in GILD in Q4 2018 and held it in 7 quarters. The position peaked at $1.54M in Q1 2019. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

Weld Capital Management reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
Weld Capital Management sold 6,050 Gilead Sciences shares in Q3 2021, an estimated $417K.
Weld Capital Management first reported a position in Gilead Sciences in Q4 2018 and held it in 7 quarters.
Weld Capital Management's Gilead Sciences position peaked at $1.54M in Q1 2019.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Weld Capital Management's 13F filing for Q3 2021.